Donggoo Bae

996 total citations
14 papers, 840 citations indexed

About

Donggoo Bae is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Donggoo Bae has authored 14 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Donggoo Bae's work include Angiogenesis and VEGF in Cancer (6 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Donggoo Bae is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Donggoo Bae collaborates with scholars based in South Korea, United States and Russia. Donggoo Bae's co-authors include Chi‐Bom Chae, Arthur M. Mercurio, Cherie Taglienti, Bryan Pursell, Irwin Leav, Vishva M. Sharma, Paul Mak, Woong Yoon, Xiaofang Yang and Hyo Jung Kang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Development.

In The Last Decade

Donggoo Bae

13 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donggoo Bae South Korea	9	477	233	201	127	107	14	840
Uwe Schlomann Germany	17	466 1.0×	307 1.3×	211 1.0×	79 0.6×	102 1.0×	28	945
Chiara Tomasello Italy	19	535 1.1×	282 1.2×	302 1.5×	162 1.3×	112 1.0×	39	1.2k
Yoshiaki Onodera Japan	23	772 1.6×	285 1.2×	260 1.3×	133 1.0×	107 1.0×	57	1.3k
Ren Xu United States	17	483 1.0×	222 1.0×	129 0.6×	111 0.9×	193 1.8×	38	1.0k
Xiaoai Zhao China	13	575 1.2×	167 0.7×	231 1.1×	75 0.6×	49 0.5×	20	1.1k
Bakhtiar Yamini United States	20	487 1.0×	158 0.7×	317 1.6×	88 0.7×	65 0.6×	44	1.0k
Raelene Endersby Australia	16	671 1.4×	234 1.0×	244 1.2×	109 0.9×	53 0.5×	39	1.2k
David M. Nanus United States	13	442 0.9×	350 1.5×	118 0.6×	200 1.6×	133 1.2×	27	902
Olga A. Agapova United States	23	914 1.9×	232 1.0×	145 0.7×	86 0.7×	138 1.3×	29	1.8k
Hemragul Sabit Japan	21	647 1.4×	210 0.9×	284 1.4×	110 0.9×	117 1.1×	47	1.2k

Countries citing papers authored by Donggoo Bae

Since Specialization

Citations

This map shows the geographic impact of Donggoo Bae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donggoo Bae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donggoo Bae more than expected).

Fields of papers citing papers by Donggoo Bae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donggoo Bae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donggoo Bae. The network helps show where Donggoo Bae may publish in the future.

Co-authorship network of co-authors of Donggoo Bae

This figure shows the co-authorship network connecting the top 25 collaborators of Donggoo Bae. A scholar is included among the top collaborators of Donggoo Bae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donggoo Bae. Donggoo Bae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Kim, Kyoung Jin, Kwanghyun Lee, Myeong Jin Yoon, et al.. (2024). GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy. BMC Immunology. 25(1). 29–29.

2.

Kim, Mi-Young, Jeong Ho Seok, Kyung‐Yong Kim, et al.. (2021). A Novel Therapeutic Anti-ErbB3, ISU104 Exhibits Potent Antitumorigenic Activity by Inhibiting Ligand Binding and ErbB3 Heterodimerization. Molecular Cancer Therapeutics. 20(6). 1142–1152. 11 indexed citations

3.

Hong, Seung‐Beom, et al.. (2020). Abstract 3042: Anti-cancer efficacy of an anti-ErbB3 antibody, ISU104, against the cancers with NRG1-overexpression, NRG1-fusion, or oncogenic ErbB3 mutations. Cancer Research. 80(16_Supplement). 3042–3042. 1 indexed citations

4.

Kim, Miyoung, et al.. (2018). Abstract 836: ISU104, a fully human anti-ErbB3 antibody, overcomes acquired cetuximab resistance. Cancer Research. 78(13_Supplement). 836–836. 2 indexed citations

5.

Kim, Miyoung, et al.. (2018). Abstract 830: ISU104, a fully human antibody targeting a specific epitope on the ErbB3, displays potent inhibition of tumor growth in multiple xenograft tumor models. Cancer Research. 78(13_Supplement). 830–830. 5 indexed citations

6.

Goel, Hira Lal, et al.. (2011). Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development. 138(14). 2969–2976. 20 indexed citations

7.

Mak, Paul, Irwin Leav, Bryan Pursell, et al.. (2010). ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading. Cancer Cell. 17(6). 622–622. 3 indexed citations

8.

Mak, Paul, Irwin Leav, Bryan Pursell, et al.. (2010). ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading. Cancer Cell. 17(4). 319–332. 310 indexed citations

9.

Bae, Donggoo, Shaolei Lu, Cherie Taglienti, & Arthur M. Mercurio. (2008). Metabolic Stress Induces the Lysosomal Degradation of Neuropilin-1 but Not Neuropilin-2. Journal of Biological Chemistry. 283(42). 28074–28080. 38 indexed citations

10.

Kim, Wan‐Uk, Soon Suk Kang, Seung‐Ah Yoo, et al.. (2006). Interaction of Vascular Endothelial Growth Factor 165 with Neuropilin-1 Protects Rheumatoid Synoviocytes from Apoptotic Death by Regulating Bcl-2 Expression and Bax Translocation. The Journal of Immunology. 177(8). 5727–5735. 55 indexed citations

11.

Yoo, Seung‐Ah, Donggoo Bae, Hae‐Rim Kim, et al.. (2005). Arginine-Rich Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Hexapeptide Inhibits Collagen-Induced Arthritis and VEGF-Stimulated Productions of TNF-α and IL-6 by Human Monocytes. The Journal of Immunology. 174(9). 5846–5855. 97 indexed citations

12.

Bae, Donggoo, Tae‐Dong Kim, Ge Li, Woong Yoon, & Chi‐Bom Chae. (2005). Anti-Flt1 Peptide, a Vascular Endothelial Growth Factor Receptor 1–Specific Hexapeptide, Inhibits Tumor Growth and Metastasis. Clinical Cancer Research. 11(7). 2651–2661. 92 indexed citations

13.

Yang, Seung‐Pil, Donggoo Bae, Hyo Jung Kang, et al.. (2003). Co-accumulation of vascular endothelial growth factor with β-amyloid in the brain of patients with Alzheimer’s disease. Neurobiology of Aging. 25(3). 283–290. 144 indexed citations

14.

Bae, Donggoo, et al.. (2000). Arginine-rich Anti-vascular Endothelial Growth Factor Peptides Inhibit Tumor Growth and Metastasis by Blocking Angiogenesis. Journal of Biological Chemistry. 275(18). 13588–13596. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact